About the Authors

Ric M. Procyshyn, BScPharm, MSc, PharmD, PhD(A, B)
Kalyna Z. Bezchlibnyk-Butler, BScPhm, FCSHP
J. Joel Jeffries, MB, FRCPC, DFCPA(C)


The Editors wish to acknowledge contributions from the following chapter co-editors:
Ana Aleksic, MScPharm(A) (Electroconvulsive Therapy, Antipsychotic-Induced Extrapyramidal Side Effects and Their Management)
Alasdair Barr, PhD(D) (Drugs of Abuse)
Andrius Baskys, MD, PhD(E) (Drugs for Treatment of Dementia, Pharmacogenomic Information for Common Psychotropic Drugs)
Renee Bjarnson, BScPharm, ACPR(F) (Treatment of Substance Use Disorders)
Sally Chai, BScPharm, BCPS(G) (Treatment of Substance Use Disorders)
Sue Corrigan, BScPharm, ACPR, PharmD(G) (Antipsychotics)
Robert Dickey, MD, FRCPC(C) (Sex-Drive Depressants)
Jane Dumontet, BScPharm, PharmD, BCPP(G) (Mood Stabilizers)
Lynda Eccott, BSc, MScPharm(H) (Natural Health Products)
Dean Elbe, BScPharm, PharmD, BCPP(I) (Drugs for ADHD)
Gary Hasey, MD, FRCPC, MSc(J) (Repetitive Transcranial Magnetic Stimulation)
Barry A. Martin, MD, FRCPC(C) (Electroconvulsive Therapy)
Roger S. McIntyre, MD, FRCPC(K) (Mood Stabilizers)
Reza Rafizadeh, BScPharm, RPh, ACPR, BCPP(G) (Antipsychotics)
Christian G. Schütz, MD, PhD, MPH, FRCPC(L) (Treatment of Substance Use Disorders, Unapproved Treatments)
Jacky T. P. Siu, BScPharm, ACPR, PharmD(G) (Anxiolytics, Hypnotics/Sedatives)
Debbie Thompson, BScPharm, PharmD, BCPP(G) (Antidepressants)
Fidel Vila-Rodriguez, MD, FRCPC, FAPA(A) (Electroconvulsive Therapy) Elisa-Marie Weatherby, BScPharm, ACPR, PharmD(G) (Antidepressants)
Bree Zehm, PharmD(M) (Antidepressants)

(A) Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
(B) British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada
(C) Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada
(D) Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada
(E) Riverside Psychiatric Medical Group Memory Disorders Program, Riverside, CA, USA
(F) Lower Mainland Pharmacy Services and Burnaby Center for Mental Health & Addiction, Burnaby, BC, Canada
(G) Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
(H) Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
(I) Children's & Women's Mental Health Programs, BC Mental Health and Substance Use Services/BC Children's Hospital, Vancouver, BC, Canada
(J) Departments of Psychiatry and Behavioural Neurosciences, Biomedical, Electrical and Computer Engineering, McMaster University, Hamilton, ON, Canada
(K) Toronto Western Hospital, University Health Network, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada
(L) Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada, and Burnaby Center for Mental Health & Addiction, Burnaby, BC, Canada
(M) Department of Pharmacy, Island Health, Victoria, BC, Canada